Kamada (KMDA) Depreciation & Amortization (CF) (2012 - 2026)

Kamada (KMDA) posted quarterly Depreciation & Amortization (CF) of $3.9 million for Q1 2026, up 6.65% year-on-year from $3.6 million in Q1 2025, and up 1.32% on a QoQ basis from $3.8 million in Q4 2025.

Kamada (KMDA) Depreciation & Amortization (CF) (2012 - 2026) Analysis & Trends

Kamada (KMDA) has reported Depreciation & Amortization (CF) for 15 consecutive years, with $3.9 million the latest figure, recorded in Q1 2026.

  • Quarterly Depreciation & Amortization (CF) rose 6.65% year-over-year to $3.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.2 million (up 6.88% YoY) and the FY2025 annual result came in at $14.9 million, up 8.04% from the prior year.
  • Depreciation & Amortization (CF) rose to $3.9 million in Q1 2026 per KMDA's latest filing, from $3.8 million in the prior quarter.
  • Over the last five years, Depreciation & Amortization (CF) for KMDA reached as high as $4.1 million in Q4 2024 and fell as low as $3012.0 in Q4 2022.
  • A 5-year average of $2.8 million and a median of $3.2 million in 2024 frame the typical range for Depreciation & Amortization (CF).
  • The largest YoY upside for Depreciation & Amortization (CF) was 106407.3% in 2023 against a maximum downside of 99.9% in 2023.
  • Year by year, Depreciation & Amortization (CF) stood at $3012.0 in 2022, then jumped by 106407.3% to $3.2 million in 2023, then climbed by 27.81% to $4.1 million in 2024, then slipped by 7.29% to $3.8 million in 2025, then increased by 1.32% to $3.9 million in 2026.
  • According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $3.9 million, $3.8 million, and $3.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 239.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 119.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 1.04 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 22.60 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 676.10 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 7.20 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 172.00 Mn
10 Kamada 401.22 Mn 328.07 Mn 19.12 Mn 3.85 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 3.85 Mn
Mar 31, 2026 3.85 Mn
Dec 31, 2025 3.80 Mn
Dec 31, 2025 3.80 Mn
Sep 30, 2025 3.76 Mn
Sep 30, 2025 3.76 Mn
Jun 30, 2025 3.75 Mn
Jun 30, 2025 3.75 Mn
Mar 31, 2025 3.61 Mn
Mar 31, 2025 3.61 Mn
Dec 31, 2024 4.10 Mn
Dec 31, 2024 4.10 Mn
Sep 30, 2024 3.24 Mn
Sep 30, 2024 3.24 Mn
Jun 30, 2024 3.23 Mn
Jun 30, 2024 3.23 Mn
Mar 31, 2024 3.24 Mn
Mar 31, 2024 3.24 Mn
Dec 31, 2023 3.21 Mn
Dec 31, 2023 3.21 Mn